Abstract:Apoptosis is an important area of research because of its role in keeping a mature multicellular organism’s number of cells constant, hence, ensuring that the organism does not have cell accumulation that may transform into cancer with additional hallmarks. Firstly, we have carried out sensitivity analysis on an existing mathematical mitochondria-dependent apoptosis model to find out which parameters have a role in causing monostable cell survival, which may, in turn, lead to malfunction in apoptosis. We have then generated three base parameter sets that represent healthy cells. These parameter sets were built by changing the sensitive parameters while preserving the bistability. For each base set, we varied the proapoptotic and antiapoptotic production rates, to yield new sets for the cells that have malfunctioning apoptosis. In a hypothetical cell model, we simulated caspase-3 activation by numerically integrating the governing ordinary differential equations of a mitochondria-dependent apoptosis model. These simulations were carried out for four potential treatments, namely: (1) proteasome inhibitor treatment, (2) Bcl-2 inhibitor treatment, (3) IAP inhibitor treatment, (4) Bid-like synthetic peptides treatment. The results suggest that the proteasome inhibitor treatment is the most effective treatment, though it may have severe side effects. For this treatment, the amount of proteasome inhibitor needed for caspase-3 activation may be different for hypothetical cells with a different pro- or anti-apoptotic protein defect. It is also found that caspase-3 can be activated by Bcl-2 inhibitor treatment only in those hypothetical malfunctioning cells with Bax deficiency but not in others. These results are in line with the view that molecular heterogeneity in individuals may be an important factor in determining the individuals’ positive or negative responses to treatments.

Robustness Analysis Identifies the Plausible Model of the Bcl-2 Apoptotic Switch

Two Independent Positive Feedbacks and Bistability in the Bcl-2 Apoptotic Switch

Modeling of the Role of A Bax-Activation Switch in the Mitochondrial Apoptosis Decision

Evaluating bistability of Bax activation switch.

Boolean network-based model of the Bcl-2 family mediated MOMP regulation

Characterization of the anti-apoptotic mechanism of Bcl-B

Analysis of a mathematical model of apoptosis: individual differences and malfunction in programmed cell death

The third model of Bax/Bak activation: a Bcl-2 family feud finally resolved?

Bcl-2 family controls mitochondrial outer membrane permeabilization by performing non-trivial pattern recognition

A Plausible Model for Bimodal P53 Switch in Dna Damage Response

A Conserved Hydrophobic Core At Bcl-X(L) Mediates Its Structural Stability And Binding Affinity With Bh3-Domain Peptide Of Pro-Apoptotic Protein

Experimental Characterization of the Binding Affinities Between Proapoptotic BH3 Peptides and Antiapoptotic Bcl-2 Proteins

Modelling of the Mitochondrial Apoptosis Network.

Bcl-2 inhibits apoptosis by increasing the time-to-death and intrinsic cell-to-cell variations in the mitochondrial pathway of cell death

Model-based analysis uncovers mutations altering autophagy selectivity in human cancer

Characterizing the consensus residue specificity and surface of BCL-2 binding to BH3 ligands using the Knob-Socket model

Differential Regulation of Bax and Bak by Anti-apoptotic Bcl-2 Family Proteins Bcl-B and Mcl-1

Parameter Sensitivity Analysis for a Stochastic Model of Mitochondrial Apoptosis Pathway

Correlation Between Oncogenic Mutations and Parameter Sensitivity of the Apoptosis Pathway Model

Low probability Bid-Bax reaction generates heterogeneity in apoptosis resistance of cancer and cancer stem cells

A trigger model of apoptosis induced by tumor necrosis factor signaling